— GLP-1 / GIP Dual Agonist
Tirzepatide

Apex of metabolic research — the dual-incretin standard.
Tirzepatide is a dual GLP-1 and GIP receptor agonist representing the current global standard for metabolic and weight-management research. Synthesized via solid-phase Fmoc chemistry and purified by reverse-phase HPLC.
Spec
10mg or 15mg · Lyophilized
Mass
10.04 mg
Purity
99.6%
Co-activates GLP-1R and GIPR pathways modulating incretin response and hepatic glucose output in vitro.
Reconstitute with 2 mL bacteriostatic water for a 5 mg/mL working concentration.
Store lyophilized at -20 °C. Once reconstituted, refrigerate at 2–8 °C and use within 28 days.
Select SKU
Price · Per Vial
$0.01
10mg
Research & Operations
Frequently Asked Questions
Clinical-grade answers to the questions that matter most in advanced research procurement.